RP
R&G PharmaStudies Co. Ltd. A
🇨🇳XSHE.301333ChinaHealthcare
CNÂ¥72.00CNYdown -0.08 (-0.11%)OpenEnd of day1:50 AM
PriceCNÂ¥72.00-0.08 (-0.11%)
Profile
- Healthcare
- Biotechnology
- China
Identity
- Exchange
- Shenzhen Stock Exchange . XSHE
- Type
- Stock
- ISIN
- CNE100005K44
- CUSIP
- Not reported
Company
- Employees
- 2,208
- Headquarters
- Beijing, China
- Website
- https://www.rg-pharma.com
Market
- Shares outstanding
- 96.6M
- Market cap
- CNÂ¥6.95B
Highlights
- Market cap
- CNÂ¥6.95B
- EPS LTM
- CNÂ¥1.48calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 48.69calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 0.14%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- CNÂ¥744.68M+0.85%up year on year
- Net income
- CNÂ¥142.83M+5.74%up year on year
- Gross margin
- 35.69%-10.55%down year on year
- Free cash flow
- CNÂ¥107.77M-44.31%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.